| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 05/24/2007 | US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 05/23/2007 | EP1787979A1 Sulfonamide derivative selectively inhibiting mmp-13 |
| 05/23/2007 | EP1786766A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 05/23/2007 | EP1786764A2 Process for preparing tamsulosin |
| 05/22/2007 | US7220914 1-methyl-3-(4-sulfoxybutyl)methylimidazolium zwitterion for photovoltaic cell charge carrier layers; increased viscosity prevents the undesired flow of the charge carrier layer to outside of the photovoltaic cell |
| 05/22/2007 | US7220884 Hydroaminomethylation of olefins |
| 05/22/2007 | US7220783 Para-terphenyl compounds |
| 05/22/2007 | CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
| 05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
| 05/18/2007 | WO2007054257A2 Indene derivatives, their preparation and use as medicaments |
| 05/18/2007 | WO2007054139A2 Styrylsulfonamides, their manufacture and use as pharmaceutical agents |
| 05/18/2007 | WO2007024611A3 Sulfonamides of 7 -aminoheptanoic acid derivatives for treating glaucoma |
| 05/18/2007 | WO2006135648A3 Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives |
| 05/18/2007 | CA2628856A1 Indene derivatives, their preparation and use as medicaments |
| 05/18/2007 | CA2607982A1 Styrylsulfonamides, their manufacture and use as pharmaceutical agents |
| 05/17/2007 | US20070111073 Mixture, cation conductor and electrochemical device using those |
| 05/16/2007 | EP1784386A2 Histone deacetylase inhibitors |
| 05/16/2007 | CN1315803C Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/15/2007 | US7217832 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 05/15/2007 | US7217737 Method and compositions for inhibiting cell proliferative disorders |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/10/2007 | WO2007052831A1 Preventives/remedies for urinary disturbance |
| 05/10/2007 | WO2006120574A3 Analogs of 4-hydroxyisoleucine and uses thereof |
| 05/10/2007 | US20070106079 Acylation, chlorination, coupling |
| 05/10/2007 | US20070105914 Substituted sulfonamides |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105829 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 05/10/2007 | US20070105750 Novel plasma protein affinity tags |
| 05/10/2007 | DE19533711B4 Verfahren zur Herstellung von einem Sulfonimid oder seinem Salz A process for producing a sulfonimide or its salt |
| 05/09/2007 | EP1029073B1 Method and agent for determining deaminase activity |
| 05/09/2007 | CN1960979A Triazolone derivatives as MMP inhibitors for the treatment of asthma and copd |
| 05/08/2007 | US7214827 To make ketoaniline derivatives, using as a catalyst a tri(perfluoroalkane sulfonate) salt of specified elements such as Gallium; bonding of acyl group to a benzene ring |
| 05/08/2007 | US7214824 useful for the treatment of pain, neuralgia, neuropathies, nerve injury, burns, migraine, carpal tunnel syndrome, fibromyalgia, neuritis, sciatica, pelvic hypersensitivity, bladder disease, inflammation, or the like in mammals, especially humans |
| 05/08/2007 | US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 05/08/2007 | US7214694 Controlling transforming growth facor; artificial skin; wound healing agents |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/03/2007 | WO2007048557A1 Protease inhibitors |
| 05/03/2007 | US20070099986 Preventives/remedies for urinary disturbance |
| 05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 05/03/2007 | US20070099826 Treatment of diseases associated with the egr-1 enhancer element |
| 05/03/2007 | US20070099117 Sulfonamide compound, polymer compound, resist material and pattern formation method |
| 05/03/2007 | DE102005052103A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005052102A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778629A1 Process for the synthesis c-2, c-3 substituted n-alkylated indoles useful as cpla2 inhibitors |
| 05/02/2007 | EP1482919B1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes |
| 05/02/2007 | EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 05/02/2007 | CN1956949A Substituted sulfonamides |
| 05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313058C Container assembly for fertilization and culture and embryo transfer |
| 05/01/2007 | USRE39607 Herbicidal sulphonylamino(thio) carbonyl compounds |
| 05/01/2007 | US7211696 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin |
| 05/01/2007 | US7211685 Carboxy group, nitro group, tert-butoxycarbonylamino group or benzyloxycarbonylamino substituted naphthalene: osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia |
| 05/01/2007 | CA2138675C Catecholamine surrogates useful as .beta.3 agonists |
| 04/26/2007 | WO2007047432A1 Sulfonamide derivatives as modulators of ppar |
| 04/26/2007 | WO2007045893A2 Beta adrenergic receptor pharmacophore |
| 04/26/2007 | WO2007045573A1 Phenyl-acetamide nnrt inhibitors |
| 04/26/2007 | WO2007045572A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/26/2007 | WO2007017511A3 Compounds for treating alzheimer's disease |
| 04/26/2007 | US20070093678 Novel perfluoroalkanesulfonamide compounds |
| 04/26/2007 | US20070093485 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 04/26/2007 | US20070093476 Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2007 | CA2625918A1 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
| 04/26/2007 | CA2625047A1 Phenyl-acetamide nnrt inhibitors |
| 04/26/2007 | CA2625039A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
| 04/25/2007 | EP1776347A1 Sulphonamide derivatives, their preparation and their therapeutic application |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
| 04/24/2007 | US7208605 Functionalized ionic liquids, and methods of use thereof |
| 04/24/2007 | US7208601 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants |
| 04/24/2007 | US7208526 For example, (E)-2-(4-Chloro-phenyl)-ethenesulfonic acid 2,4-dichloro-benzoylamide; for use in the control or prevention of illnesses such as cancer; antitumor agents |
| 04/24/2007 | US7208524 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 04/24/2007 | US7208521 Selective inhibitors of the urokinase plasminogen activator |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2289472C Excitatory amino acid receptor modulators |
| 04/19/2007 | WO2007043274A1 Polyarylene and process for producing the same |
| 04/19/2007 | WO2007042817A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 04/19/2007 | WO2007009798A3 Process of sulfonating 4-aminobenzonitriles |
| 04/19/2007 | US20070088165 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/19/2007 | US20070088142 Perfluorovinyl ether monomer having a sulfonamido group |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | CA2625339A1 Polyarylene and method for producing the same |
| 04/19/2007 | CA2620363A1 Naphthalene-disulfonamides useful for the treatment of inflammation |
| 04/18/2007 | EP1773763A1 Lysine based compounds |
| 04/18/2007 | EP1773762A2 Methods and compounds for detection of medical disorders |
| 04/18/2007 | EP1773750A1 Chemical compounds |
| 04/18/2007 | CN1950354A Process for making n-sulfonated-amino acid derivatives |
| 04/18/2007 | CN1310882C Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof |
| 04/18/2007 | CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I |
| 04/17/2007 | CA2289005C Method for the synthesis of perfluorosulphonamides, perfluorosulphonamides and their salts, and a sulphonation reagent |
| 04/17/2007 | CA2250586C Meta-substituted phenylene sulphonamide derivatives |
| 04/12/2007 | WO2007039736A1 Novel compounds |
| 04/12/2007 | WO2007039125A2 An optically active thyroid receptor agonist and optically active key intermediates in its production |
| 04/12/2007 | US20070082907 Peroxisome proliferator activated receptor modulators |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082883 HIV protease inhibitors |